Metadon Dne Pharma (Methadone Hydrochloride)

Methadone is an opioid medication used in the treatment of opioid dependence and related conditions.

• Opioid dependence: reduces withdrawal symptoms and cravings during maintenance therapy.
• Chronic pain: provides long‑acting analgesia for severe, persistent pain when other options are insufficient.
• Detoxification: facilitates supervised opioid withdrawal in clinical settings.

• Methadone acts as a full agonist at the mu‑opioid receptors, producing analgesia and suppressing withdrawal by stabilizing neuronal activity. It also antagonizes NMDA receptors, which may help mitigate opioid tolerance and hyperalgesia. The drug is metabolized primarily by hepatic CYP3A4 and CYP2B6 enzymes, influencing its plasma levels and interactions.

Adverse reactions may vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Constipation: reduced bowel movements.
• Sweating: excessive perspiration.
• Drowsiness: feeling unusually sleepy.
• Dry mouth: reduced salivation.
• Headache: mild to moderate pain.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing, potentially life‑threatening.
• QT prolongation: heart rhythm disturbance.
• Severe hypotension: marked drop in blood pressure.
• Seizures: uncontrolled electrical activity in the brain.
• Allergic reactions: rash, itching, swelling.
• Adrenal insufficiency: fatigue, weakness, low blood pressure.

Before prescribing methadone, clinicians should consider several safety measures.

• Cardiac risk assessment: monitor QT interval in patients with cardiac history.
• Liver function evaluation: adjust dosing in hepatic impairment.
• Respiratory monitoring: watch for depression, especially in opioid‑naïve individuals.
• Concomitant CNS depressants: avoid or use with caution to reduce sedation risk.
• Dependence potential: counsel patients on misuse and diversion.
• Store at ambient temperature: keep in original packaging, protect from moisture and light.

Methadone can interact with a range of medicines, requiring careful management.

Major Interactions (Avoid)

• Combined CNS depressants (e.g., benzodiazepines, alcohol): increased risk of respiratory depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise methadone levels.
• QT‑prolonging agents (e.g., sotalol, quinidine): additive cardiac risk.

Moderate Interactions (Monitor Closely)

• CYP2B6 inducers (e.g., rifampin): may lower methadone concentrations.
• Certain antidepressants (e.g., SSRIs): can affect methadone metabolism.
• NSAIDs: increase risk of gastrointestinal bleeding when combined with methadone.